Anika Therapeutics Inc (NAS:ANIK)
$ 17.35 -0.2 (-1.14%) Market Cap: 254.10 Mil Enterprise Value: 219.27 Mil PE Ratio: 0 PB Ratio: 1.42 GF Score: 70/100

Anika Therapeutics Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 14, 2022 / 12:00PM GMT
Release Date Price: $23.19 (-5.23%)
Mike Matson
Needham & Company, LLC - Analyst

Good morning. Thank you for joining us at the 21st annual Needham healthcare conference. I'm Mike Matson, Senior Research Analyst on the medtech and diagnostics team. Next up, we have a presentation from Anika. Presenting from Anika, we have President and CEO, Cheryl Blanchard; CFO, Mike Levitz; and VP of Investor Relations, Mark Namaroff. Anika will give a presentation, and then we'll follow up with some Q&A. (Conference Instructions)

So with that, I'll turn it over to Cheryl, and then we can get started with the presentation. Thanks.

Cheryl Blanchard
Anika Therapeutics, Inc. - President & CEO

Great. Thanks, Mike, and good morning, everybody. I'd like to thank you all for joining us and just have you all keep in mind that we will have some forward-looking statements and some non-GAAP financial measures in our presentation this morning.

Let me dive right into the content. This is just a quick snapshot about Anika. Anika is actually in our 30th year of doing business this year and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot